poly(ethylene glycol)diacrylate

structure in first source

Also Known As:

PEG 700 diacrylate; PEG-DA; poly(ethylene glycol)-diacrylate macromer; poly(ethyleneglycol) diacrylate; poly(ethyleneglycol)diacrylate; polyethyleneglycol 700 diacrylate; polyethyleneglycol diacrylate

Networked: 43 relevant articles (2 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Wu, Jun: 2 articles (02/2022 - 08/2021)
2.	Guerra, Alberto Daniel: 2 articles (01/2017 - 01/2017)
3.	Kao, W John: 2 articles (01/2017 - 01/2017)
4.	Brennecka, Celeste R: 2 articles (11/2013 - 06/2013)
5.	Soodak, Kristen F: 2 articles (11/2013 - 06/2013)
6.	Vernon, Brent L: 2 articles (11/2013 - 06/2013)
7.	Huang, Jun: 1 article (02/2022)
8.	Liu, Guiting: 1 article (02/2022)
9.	Xu, Zejun: 1 article (02/2022)
10.	Anbiah, Benjamin: 1 article (01/2022)

Related Diseases

1.	Neoplasms (Cancer) 08/01/2014 - "Combining such a unique behavior with subsequently slow efflux of DOX, NGO-PEG-DA/DOX offers remarkably improved cell killing for drug-resistant cancer cells under the tumor microenvironmental pH in comparison with free DOX. " 08/01/2016 - "This scaffold is generated from the cryogelation of poly(ethylene glycol) diacrylate to produce a defined elastic modulus for prostate tumor growth. " 01/01/2018 - "Therefore, we believe PEG-DA-CuS NPs are able to serve as a kind of cytotoxic and efficient photothermal agent to kill cancer." 01/01/2018 - "Tailor-made PEG-DA-CuS nanoparticles enriched in tumor with the aid of retro Diels-Alder reaction triggered by their intrinsic photothermal property." 12/01/2021 - "As demonstrated by a Dox cumulative release study and posteriorly confirmed by an efficacy assay in an in vitro colorectal cancer model, the formulation composed by NIPAM and 4-penten-1-ol crosslinked with poly(ethylene glycol) diacrylate (PEGDA) (PNiPenPH) present a slow release over the time, presenting ideal properties to become and ideal depot system for the local sustained release of anticancer drugs as adjuvant therapy or in the case of non-resectable tumors."
2.	Weight Loss (Weight Reduction) 11/01/2002 - "The molecular weight between cross-links had a significant effect on weight loss after 12 weeks, where samples with M(C) of 1,880 +/- 320 synthesized with a P(PF-co-EG):PEG-DA ratio of 3:1 had a significantly greater mass loss due to degradation than those with M(C) of 1,000 +/- 100 synthesized with a P(PF-co-EG):PEG-DA ratio of 1:1. In contrast, porosity played a minimal role in determining the weight loss. "
3.	Wounds and Injuries (Trauma) 12/29/2022 - "To overcome this challenge, we designed a poly(ethylene glycol) diacrylate (PEGDA) hydrogel with the potential capacity to sequester autologous GFs directly from the wound site. " 01/01/2023 - "This work aimed to develop a high porosity poly(ethylene glycol) diacrylate hydrogel foam that can both rapidly remove exudate and provide self-tuning moisture control to prevent wound dehydration. " 08/11/2021 - "Hydrogel wound dressings have been developed by incorporating PUE or FA via PDA nanoparticles (NPs) into polyethylene glycol diacrylate (PEG-DA) hydrogel. " 02/16/2022 - "The PEG-DA/HA-PBA/MY (PHM) hybrid hydrogel achieved glucose-triggered MY release, efficient ROS-scavenging (>80.0%), and also reshaped the hostile oxidative wound microenvironment (reduced MDA activity and increased SOD and GSH/GSSG levels). " 11/01/2019 - "A thiol-derivatized hyaluronan hydrogel cross-linked with polyethyleneglycol diacrylate (PEGDA) was used to topically deliver a cyclized epiviosamine: cP12 and a cyclized engineered variant of cP12 termed cNP8 to porcine, full-thickness, excisional wounds. "
4.	Breast Neoplasms (Breast Cancer) 04/07/2014 - "We report here a novel non-UV-based technique to quickly micropattern a poly-(ethylene) glycol diacrylate (PEGDA)-based hydrogel on top of modified glass substrates, which were then used to control the growth patterns of breast cancer cells. " 03/01/2010 - "Breast cancer cells (MDA-MB231) were dispersed in a 30 wt % solution of poly(ethylene glycol) diacrylate (PEGDA) of molecular weight 400 at a density of 5 x 10(6) cells/mL of PEGDA solution. " 12/01/2022 - "In this study, we employ biosynthetic hybrid hydrogels composed of poly(ethylene glycol diacrylate) (PEGDA) covalently conjugated to natural protein (fibrinogen) (PEG-fibrinogen, PF) to create monodisperse microspheres encapsulating breast cancer cells for 3D culture and tumorigenic characterization. "
5.	Burns 01/01/2013 - "Structural effects in photopolymerized sodium AMPS hydrogels crosslinked with poly(ethylene glycol) diacrylate for use as burn dressings." 01/01/2020 - "In this study, we developed an enhanced approach to deliver adipose-derived stem cells (ASCs) for the treatment of burn wounds, using an in-situ-formed hydrogel system comprised of a hyperbranched poly(ethylene glycol) diacrylate (HB-PEGDA) polymer, a commercially available thiol-functionalized hyaluronic acid (HA-SH) and a short RGD peptide. "

Related Drugs and Biologics

1.	poly(propylene fumarate-co-ethylene glycol)
2.	Hydrogels
3.	Hyaluronic Acid (Hyaluronan)
4.	Polymers
5.	Alginates
6.	Sulfhydryl Compounds (Thiols)
7.	Glucose (Dextrose)
8.	Fibrinogen (Factor I)
9.	Proteins (Proteins, Gene)
10.	Methacrylates

Related Therapies and Procedures

1.	Therapeutics
2.	Microspheres (Microsphere)
3.	Drug Therapy (Chemotherapy)
4.	Nanospheres
5.	Photochemotherapy (Photodynamic Therapy)